Cardiol Therapeutics Inc. Adjustments For Decrease Increase In Other Operating Receivables
Cardiol Therapeutics Inc. (CRDL) reported Adjustments For Decrease Increase In Other Operating Receivables of CAD 90.79 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables · last filed 2026-03-31
| Period end | Adjustments For Decrease Increase In Other Operating Receivables 12 month |
|---|---|
| 2025-12-31 | 90.79K CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | -124.13K CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 133.15K CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | 71.11K CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | -127.26K CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | 702.07K CAD 20-F · filed 2023-03-29 |